These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 32591439)

  • 21. Association of Longitudinal Trajectories of Systolic BP with Risk of Incident CKD: Results from the Korean Genome and Epidemiology Study.
    Joo YS; Lee C; Kim HW; Jhee J; Yun HR; Park JT; Chang TI; Yoo TH; Kang SW; Han SH
    J Am Soc Nephrol; 2020 Sep; 31(9):2133-2144. PubMed ID: 32759227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association Between the Frailty and Cognitive Impairment Among Patients With Hypertension-A Post Hoc Analysis of the SPRINT Trial.
    Wang Z; Wang Q; Pei J; Wang X; Li Y; Yan J; Du X
    J Am Heart Assoc; 2023 Apr; 12(7):e028736. PubMed ID: 36974773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of vigorous-intensity physical activity on incident cognitive impairment in high-risk hypertension.
    Kazibwe R; Schaich CL; Muhammad AI; Epiu I; Namutebi JH; Chevli PA; Kazibwe J; Hughes T; Rikhi RR; Shapiro MD; Yeboah J
    Alzheimers Dement; 2024 Jul; 20(7):4602-4612. PubMed ID: 38842100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of low blood pressure in cognitively impaired elderly patients treated with antihypertensive drugs.
    Mossello E; Pieraccioli M; Nesti N; Bulgaresi M; Lorenzi C; Caleri V; Tonon E; Cavallini MC; Baroncini C; Di Bari M; Baldasseroni S; Cantini C; Biagini CA; Marchionni N; Ungar A
    JAMA Intern Med; 2015 Apr; 175(4):578-85. PubMed ID: 25730775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary Biomarkers of Tubular Damage Are Associated with Mortality but Not Cardiovascular Risk among Systolic Blood Pressure Intervention Trial Participants with Chronic Kidney Disease.
    Jotwani VK; Lee AK; Estrella MM; Katz R; Garimella PS; Malhotra R; Rifkin DE; Ambrosius W; Freedman BI; Cheung AK; Raphael KL; Drawz P; Neyra JA; Oparil S; Punzi H; Shlipak MG; Ix JH;
    Am J Nephrol; 2019; 49(5):346-355. PubMed ID: 30939472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Orthostatic blood pressure changes do not influence cognitive outcomes following intensive blood pressure control.
    Jiang C; Zhao M; Li M; Wang Z; Bai Y; Guo H; Li S; Lai Y; Wang Y; Gao M; He L; Guo X; Li S; Liu N; Jiang C; Tang R; Long D; Sang C; Du X; Dong J; Anderson CS; Ma C
    J Intern Med; 2024 Apr; 295(4):557-568. PubMed ID: 38111091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood Pressure, Chronic Kidney Disease Progression, and Kidney Allograft Failure in Kidney Transplant Recipients: A Secondary Analysis of the FAVORIT Trial.
    Malhotra R; Katz R; Weiner DE; Levey AS; Cheung AK; Bostom AG; Ix JH
    Am J Hypertens; 2019 Aug; 32(9):816-823. PubMed ID: 31179500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 24-Hour Blood Pressure Variability Via Ambulatory Monitoring and Risk for Probable Dementia in the SPRINT Trial.
    Sible IJ; Nation DA
    J Prev Alzheimers Dis; 2024; 11(3):684-692. PubMed ID: 38706284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Intensive BP Control in CKD.
    Cheung AK; Rahman M; Reboussin DM; Craven TE; Greene T; Kimmel PL; Cushman WC; Hawfield AT; Johnson KC; Lewis CE; Oparil S; Rocco MV; Sink KM; Whelton PK; Wright JT; Basile J; Beddhu S; Bhatt U; Chang TI; Chertow GM; Chonchol M; Freedman BI; Haley W; Ix JH; Katz LA; Killeen AA; Papademetriou V; Ricardo AC; Servilla K; Wall B; Wolfgram D; Yee J;
    J Am Soc Nephrol; 2017 Sep; 28(9):2812-2823. PubMed ID: 28642330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BP Reduction, Kidney Function Decline, and Cardiovascular Events in Patients without CKD.
    Magriço R; Bigotte Vieira M; Viegas Dias C; Leitão L; Neves JS
    Clin J Am Soc Nephrol; 2018 Jan; 13(1):73-80. PubMed ID: 29101186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alcohol Consumption and Risk of Dementia and Cognitive Decline Among Older Adults With or Without Mild Cognitive Impairment.
    Koch M; Fitzpatrick AL; Rapp SR; Nahin RL; Williamson JD; Lopez OL; DeKosky ST; Kuller LH; Mackey RH; Mukamal KJ; Jensen MK; Sink KM
    JAMA Netw Open; 2019 Sep; 2(9):e1910319. PubMed ID: 31560382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between blood pressure levels and cognitive impairment in older women: a prospective analysis of the Women's Health Initiative Memory Study.
    Liu L; Hayden KM; May NS; Haring B; Liu Z; Henderson VW; Chen JC; Gracely EJ; Wassertheil-Smoller S; Rapp SR
    Lancet Healthy Longev; 2022 Jan; 3(1):e42-e53. PubMed ID: 35112096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Visit-to-Visit Variability of BP and CKD Outcomes: Results from the ALLHAT.
    Whittle J; Lynch AI; Tanner RM; Simpson LM; Davis BR; Rahman M; Whelton PK; Oparil S; Muntner P
    Clin J Am Soc Nephrol; 2016 Mar; 11(3):471-80. PubMed ID: 26912544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. No Association between Dietary Patterns and Risk for Cognitive Decline in Older Women with 9-Year Follow-Up: Data from the Women's Health Initiative Memory Study.
    Haring B; Wu C; Mossavar-Rahmani Y; Snetselaar L; Brunner R; Wallace RB; Neuhouser ML; Wassertheil-Smoller S
    J Acad Nutr Diet; 2016 Jun; 116(6):921-930.e1. PubMed ID: 27050728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimated glomerular filtration rate and the risk-benefit profile of intensive blood pressure control amongst nondiabetic patients: a post hoc analysis of a randomized clinical trial.
    Obi Y; Kalantar-Zadeh K; Shintani A; Kovesdy CP; Hamano T
    J Intern Med; 2018 Mar; 283(3):314-327. PubMed ID: 29044764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endothelial dysfunction and subsequent decline in glomerular filtration rate in hypertensive patients.
    Perticone F; Maio R; Perticone M; Sciacqua A; Shehaj E; Naccarato P; Sesti G
    Circulation; 2010 Jul; 122(4):379-84. PubMed ID: 20625109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and Risk of Severe Cognitive Impairment in Advanced Chronic Kidney Disease.
    Burns CM; Knopman DS; Tupper DE; Davey CS; Slinin YM; Lakshminarayan K; Rossom RC; Pederson SL; Gilbertson DT; Murray AM
    J Gerontol A Biol Sci Med Sci; 2018 Mar; 73(3):393-399. PubMed ID: 29244090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kidney function changes and their relation with the progression of cerebral small vessel disease and cognitive decline.
    Jiménez-Balado J; Riba-Llena I; Pizarro J; Palasí A; Penalba A; Ramírez C; Maisterra O; Espinel E; Ramos N; Pujadas F; Serón D; Delgado P
    J Neurol Sci; 2020 Feb; 409():116635. PubMed ID: 31869590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Blood Pressure Lowering With Incident Dementia or Cognitive Impairment: A Systematic Review and Meta-analysis.
    Hughes D; Judge C; Murphy R; Loughlin E; Costello M; Whiteley W; Bosch J; O'Donnell MJ; Canavan M
    JAMA; 2020 May; 323(19):1934-1944. PubMed ID: 32427305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systolic Blood Pressure Time in Target Range and Cognitive Outcomes: Insights From the SPRINT MIND Trial.
    Li S; Jiang C; Wang Y; Lai Y; Zhao M; Li Q; Bai Y; Dai W; Guo Q; He L; Guo X; Wang W; Li S; Liu N; Jiang C; Tang R; Sang C; Long D; Du X; Dong J; Anderson CS; Ma C
    Hypertension; 2023 Aug; 80(8):1628-1636. PubMed ID: 37165869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.